OBJECTIVES: Despite claims of feasibility, to date no study has examined the effect of systematic bilateral internal mammary artery (BIMA) use in a large cohort of real-world unselected patients. The CATHolic University EXtensive BIMA Grafting Study (CATHEXIS) registry was designed to assess the feasibility and safety of systematic BIMA grafting.
INTRODUCTION
Despite several guidelines and position papers recommending a wider use of bilateral internal mammary arteries (BIMAs) [1] [2] [3] , no study has been published on the feasibility of systematic BIMA use. In all the published studies, the use of BIMA has been restricted to a portion of the overall population, and the BIMA group has in some way been selected by the operating surgeons.
In October 2012, we started a complete re-engineering of our institutional strategy for coronary artery bypass grafting (CABG) surgery towards a systematic adoption of BIMA grafting.
At that time, the evidence of the clinical benefits associated with BIMA use was even more solid than today. The literature was almost unanimously concordant in reporting that BIMA use did not increase operative mortality and morbidity, even in subgroups of high-risk patients [4] [5] [6] . A very large body of observational evidence summarized in 2 independent meta-analyses showed significant long-term survival benefit using BIMA for CABG, without adverse effect in terms of mortality [7, 8] .
According to the 2010 Guidelines of the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for CardioThoracic Surgery (EACTS), complete revascularization with arterial grafts was a Class IA recommendation for patients with reasonable life expectancy [9] .
Our centre had a very solid tradition with the use of arterial grafts for CABG, and at that time, approximately 70-80% of our patients referred for non-emergent CABG received more than 1 arterial graft. BIMA was used in almost half of the cases, and the radial artery was extensively used.
Despite our good results, the evidence supporting the use of BIMA was clearly superior to that supporting the radial artery.
On this basis, we decided to progressively adopt systematic BIMA grafting in every patient referred to our institution who met the criteria depicted in guidelines.
The CATHolic University EXtensive BIMA Grafting Study (CATHEXIS) registry was designed to record this transition and to assess the feasibility and safety of systematic use of BIMA for treatment of multivessel coronary artery disease in an unrestricted consecutive cohort of patients undergoing CABG at a large academic cardiac surgery department.
After an initial phase of progressive increase in the rate of BIMA use, the CATHEXIS was started on 16 April 2012. We herein report our results.
MATERIALS AND METHODS

Study design
The CATHEXIS was an observational, non-randomized singlecentre study started on 16 April 2012 at the Department of Cardiovascular Medicine of the Catholic University of Rome (ClinicalTrials.gov, identifier NTC01593865). The trial was aimed at prospectively including 500 patients undergoing primary nonemergent isolated multivessel CABG with BIMA and to compare them with a retrospective cohort of 500 historic propensitymatched controls.
Exclusion criteria were emergency status, previous cardiac operation, associated cardiac procedures other than CABG, preoperative left ventricular ejection fraction <30% and expected life expectancy <5 years.
End points
The primary end point of the CATHEXIS was to assess whether systematic BIMA grafting was feasible as a routine intervention in the clinical practice of a large academic cardiac surgery centre. Systematic BIMA grafting would have been considered feasible if the trial inclusion rate (number of BIMA patients versus total number of eligible patients) would have been > _80% during the study period.
As there was already solid evidence on the safety of BIMA and based on the available literature, our study was underpowered to detect differences in clinical outcomes, we considered safety a secondary end point. The secondary end point of the CATHEXIS was to evaluate differences in the rate of major adverse cardiac events (death, acute myocardial infarction, graft failure) and in the rate of sternotomy-related complications between the CATHEXIS patients and a control retrospective CABG group.
A first interim efficacy analysis was planned after enrolment of the first 100 BIMA patients, and safety analyses were scheduled after enrolment of 200, 300 and 400 BIMA patients.
Because of the observational nature of the study and the fact that the intervention was a Class IA recommendation according to the contemporary guidelines, no specific consent to participate in the CATHEXIS was requested. All patients consented to the surgical procedure and data collection.
Patient groups
The prospective arm (BIMA Group) was supposed to enrol 500 consecutive patients undergoing CABG with BIMA. The eligibility and the best revascularization strategy in each patient were assessed by the local Heart Team on the basis of clinical and anatomical conditions.
The retrospective group (pre-CATHEXIS group) was designed to consist of 500 consecutive, historical control patients who received standard CABG from March 2012 going backwards. For this analysis, the control group consisted of patients operated on between January 2009 and March 2012. The percentage of BIMA use in this group was approximately 50% (Supplementary Material, Fig. S1 ).
Data collection
The data of patients in the BIMA study group were prospectively recorded in a datasheet divided into a preoperative section, an intraoperative section and a postoperative section.
The preoperative data included age, gender, weight, height, body mass index (BMI), the presence of renal failure (defined as serum creatinine level >2.0 mg/dl), diabetes (defined as glucose blood levels >126 mg/dl or antidiabetic therapy) or chronic obstructive pulmonary disease, left ventricular ejection fraction (measured by Simpson rule using 2-dimensional echocardiography) and the logistic EuroSCORE. Obesity was defined as BMI >30 kg/m 2 . The intraoperative data included total operative time (from skin incision to skin closure), cardiopulmonary bypass time, cross-clamping time, type of conduits used, their configuration and coronary targets; for each bypass mean flow, pulsatility index and backward flow, measured by intraoperative transit-time flowmetry, were recorded.
The postoperative data included bleeding in the first 24 h, the need for blood transfusion, type and number of postoperative complications and duration of the intensive care unit stay and inhospital stay. Postoperative myocardial infarction was defined according to the universal definition in use at that time [10] .
The same data were collected for patients included in the retrospective control group of patients from the electronic database of our hospital. Data of the control group were also prospectively collected.
Per institutional protocols, we are very aggressive in performing control reangiography in the postoperative period [11] . Clinical, laboratory, ECG or echocardiographic evidence of ischaemia, as well as arrhythmias, prolonged low cardiac output, and marginal results at intraoperative flowmetric evaluation were indication for reangiography.
Surgical technique
All cases were operated using full median sternotomy, normothermic cardiopulmonary bypass, single aortic clamping and isothermic, intermittent, antegrade blood cardioplegia.
Internal mammary arteries were harvested skeletonized and used to graft the main target vessels. Additional radial artery or saphenous vein grafts were used to complete revascularization. The 2 mammary arteries were used either in situ or as a Y graft depending on the anatomy of the coronary arteries and the surgeon's intraoperative choice. The use of sequentials, double Y grafts and alternative inflow sources were also allowed.
Intraoperative flowmetric evaluation was used in all cases.
Statistical analysis
Demographic and clinical data are presented as frequency distributions and simple percentages. Values of continuous variables are expressed as mean ± standard deviation. For propensity matching, a propensity score was generated for each patient from a multivariable logistic regression model based on the following preoperative covariates: age, gender, diabetes, chronic pulmonary disease, renal insufficiency, obesity, preoperative ejection fraction and EuroSCORE, with treatment type (control versus the CATHEXIS) as a binary dependent variable. The resulting propensity score represented the probability that a patient underwent BIMA grafting. BIMA patients were then matched to the standard CABG patients in a 1:1 ratio using a Rosenbaum optimal matching algorithm and a caliper size of 0.05. This approach minimized the overall distance between observations and was conducted using the Mahalanobis distance within propensity score calipers (no matches outside the calipers). The quality of the match was assessed using standardized difference.
To assess differences in matched cohorts, the McNemar test was used to test categorical variables and paired t-test for continuous variables.
All analyses were performed using the Number Cruncher Statistical Systems software (Version 8, Copyright 2012, NCSS, Kaysville, UT, USA) and Stata (Version 12, Copyright 2012, StataCorp LP, College Station, TX, USA).
RESULTS
From 16
April 2012 to 14 March 2013, 226 patients matching the inclusion criteria were referred to our centre. Of these, 11 (4.9%) patients were excluded preoperatively due to anatomical considerations on the status and quality of the target vessels. Another 15 (6.6%) patients were excluded intraoperatively for technical problems or considerations related to the quality of the conduits or the target vessels.
Two hundred patients of the 226 (88.5%) patients received BIMA.
Demographic characteristics
The demographic and clinical characteristics of the 200 BIMA patients are listed in Table 1 . The mean age was 66 ± 9 years, and the great majority of patients were men. The mean preoperative ejection fraction was 56 ± 8%, and the mean preoperative EuroSCORE was 3.7 ± 3.9.
Perioperative data
The mean number of grafts, arterial grafts and grafts with mammary artery per patient was 2.60 ± 0.70, 2.40 ± 0.72 and 2.38 ± 0.65, respectively. In 178 (89%) patients, the mammary arteries were used in Y graft configuration. Total arterial revascularization was obtained in 138 (69%) cases. Table 2 shows the targets of the internal mammary arteries and Table 3 the results of the intraoperative flow evaluation.
The mean ± standard deviation operating time, clamping time and cardiopulmonary bypass time were 277 ± 44, 53 ± 16, 64 ± 17 min, respectively.
Postoperative data
The main postoperative complications are shown in Table 4 . Four patients died: 2 due to multiorgan failure, 1 due to arrhythmia and 1 due to perioperative myocardial infarction. There were 7 (3.5%) perioperative myocardial infarctions. No postoperative stroke occurred.
Other complications were atrial fibrillation (22.5%) and reoperation for bleeding (3.5%).
Nine patients were submitted to control reangiography before discharge. Six of them (3% of the overall BIMA cohort) underwent percutaneous intervention due to graft failure. The culprit graft was always the left or right branch of the Y graft. In the remaining 3 cases, the angiographic findings were occlusion of an ungrafted coronary artery, diffuse coronary artery spasm and normal findings (1 case each).
Mean stay in the intensive care unit and hospital after surgery was 2.55 ± 1.86 and 7.32 ± 4.00 days, respectively.
Sternal wound complications occurred in 11 (5.5%) patients. Ten of them were diabetics (6 insulin dependent and 4 noninsulin dependent), so that the incidence of sternal complications in diabetics was 14% (10 of 71). Eight sternal complications (4%) were deep (involving the sternum), whereas the remaining 3 were superficial (limited to skin and subcutaneous tissue).
Mean hospital stay for patient with sternal complications was 30 ± 14 days.
Data of the unmatched control population are given in the Supplementary Material, Table S1 . Propensity matching led to 2 groups of 150 pairs with minimal residual imbalance ( Table 5 ). The Y graft was used in 137 (91.3%) patients in the CATHEXIS group and in 38 (25.3%) in the control group (P < 0.001). When compared with patients operated in the pre-CATHEXIS era, BIMA patients had higher (although not significantly) rates of death and myocardial infarction and a significantly higher incidence of graft failure, sternal complications and major cardiac events (Table 6 ). In the control group, no patients had to be submitted to control reangiography.
On the basis of aforementioned data, the CATHEXIS was stopped for safety reasons on 14 March 2013. We went back to our pre-CATHEXIS grafting strategy.
DISCUSSION
We have a long-standing tradition in coronary surgery. In the early 90s, we pioneered the use of arterial grafts [12] [13] [14] . All the surgeons involved in the CATHEXIS had more than 10 years of experience with the use of BIMA. For some of them, the years of experience with BIMA were 15 or 20. The majority of us were using a second arterial graft in 70-80% of their CABG cases before starting the CATHEXIS, although often the second arterial graft was the radial artery.
The available evidence at the time of the CATHEXIS was clearly supporting the safety and effectiveness of BIMA in improving postoperative outcomes [4] [5] [6] [7] [8] , and according to the guidelines, complete revascularization with arterial grafts was a Class IA recommendation for patients with reasonable life expectancy [1, 2] . The evidence in support of the use of BIMA appeared more solid that the one in favour of the use of the radial artery and the routine use of BIMA had often been advocated.
On this basis, we were confident that re-engineering our CABG strategy towards the systematic use of BIMA was a step in the right direction.
After the CATHEXIS, we went back to a strategy for frequent use of the radial artery and careful individualization of the choice of the arterial conduits in accordance with the characteristics of a single patient. Our results went back to the pretrial era very quickly, and we were able to maintain the percentage of the use of a second arterial graft at approximately 80% of our CABG population.
Although bad experiences with systematic BIMA use are often the subject of conversation in the hallways of national and international meetings, they are very rarely brought to the podium.
To date, no study on systematic use of BIMA has been published. Indeed, in almost all of the existing studies, the operation has been reserved to a selected portion of the total of CABG cases. In a recent publication using the SWEDEHEART registry, the percentage of BIMA use in a nationwide real-world setting was 1% [15] .
The process of preoperatively selecting the patients on the basis of their clinical and angiographic characteristics and the Table 4 : Postoperative course of the 200 CATHEXIS patients Death, n (%) 4 (2) Atrial fibrillation, n (%) 45 (22.5) Myocardial infarction, n (%) 7 (3.5) Reintervention for bleeding, n (%) 7 (3.5) Prolonged ventilatory support, n (%) 6 (3) Delirium, n (%) 1 (0.5) Graft failure, n (%) 6 (3) Sternal complications, n (%) 11 (5.5) surgeon's technical skill is probably the key in determining the safety and long-term results of BIMA. When this process is abandoned and BIMA becomes a per-protocol choice, safety can be jeopardized. The Arterial Revascularization Trial (ART) is the only large-scale study where the decision to use BIMA was based on the randomization process and not on the decision of the operating surgeon [16] . However, even in ART, only 28% of the patients who met the eligibility criteria were actually randomized, so that a process of preselection was clearly part of the study.
Also, in ART, 16.4% of patients randomized to BIMA received a single mammary at surgery. This high percentage of crossover expresses the technical difficulty of systematically using BIMA. This is even more notable because in ART, the participating surgeons were selected based on their experience with BIMA grafting and were considered experts of the technique. In the CATHEXIS, 88.4% of the eligible patients received BIMA, and the crossover from BIMA to single mammary was 6.9%.
There is no doubt that the use of BIMA substantially increases the technical complexity of the operation. In the majority of the cases, skilled surgeons with adequate experience can overcome the technical difficulties. In most situations, there are technical solutions to overcome length, calibre and geometric issues (although at the price of exponentially increasing complexity). The use of skeletonization, multiple sequentials, Y or double Y grafts and alternative inflow sources are part of this armamentarium and allow the use of BIMA in a selected majority of CABG cases. As a group, we were all familiar with these techniques.
However, when we started using BIMA in a systematic fashion moving from our standard 50% to almost 90% BIMA use, we faced with the reality that the systematic adoption of these technical modifications can lead to suboptimal results.
In 89% of our BIMA patients, we used the Y graft. This technical solution was necessary to reach distal target vessels and maximize the completeness of revascularization. The Y graft is known to have complex flow dynamics and to be more sensitive to flow competition and flow diversion when compared with the in situ graft [17] . It is conceivable to hypothesize that the risk of graft occlusion is higher when systematically using the Y graft rather than the in situ configuration for BIMA. In fact, the safety of the Y graft has been demonstrated by 1 randomized trial and observational studies [18] [19] [20] . However, in none of these studies, the Y configuration was used on a systematic basis. In Glineur's randomized trial, only 23.4% (301 of 1297) of the overall CABG population was considered eligible and randomized for the trial [18] .
In our series, all graft failures were observed in Y grafts, suggesting that the routine and unrestricted adoption of this configuration can jeopardize patency. It is possible that our results would have been different with a more extensive use of the in situ BIMA. On the other hand, the use of the Y graft was often mandate by the necessity to graft distal or multiple targets.
A special note of concern is the very high incidence of sternal complications, in particular, in diabetics. Ten of the 11 patients who had sternal complications were in fact diabetics, and of them, 6 were also obese. Sternal complications were the most frequent adverse event in the CATHEXIS series and were the major determinant of the statistical difference in postoperative outcome between groups.
The results of the ART are similar to ours in reporting a significantly higher incidence of sternal complications in the BIMA series [16] .
The use of the radial artery as the second arterial conduit makes the use of multiple arterial grafts technically easier and safer in terms of sternal complications. Technically, the radial artery is very similar to a vein graft, and because of its superior length and diameter and thicker wall, it is much more versatile and easy to use than the second mammary. Clearly, harvesting of the radial artery does not increase the risk of sternal complications.
It is likely that with an extensive use of both the radial artery and the right mammary, a percentage of use of the second arterial graft similar to that reported in the CATHEXIS can be achieved without the increase in the operative risk seen in the ART and in the CATHEXIS.
The fact that at 5 years the ART did not show any clinical benefit for the addition of a second mammary graft [16] , while a post hoc analysis found that the use of the radial artery to supplement single and double mammaries was associated with a lower risk for mid-term major adverse cardiac events [21] and the high crossover rate in the BIMA group in the ART seems to support this hypothesis.
Limitations
Several limitations of this study must be acknowledged. The CATHEXIS was an observational registry whose primary aim was to show feasibility. Hence, no formal sample size calculation was performed for the comparison between BIMA and the previous revascularization strategy. The use of propensity matching cannot account for unmeasured confounding and propensity matched observational studies are far less rigorous than randomized trials. Also, the comparison of consecutive cohorts instead of contemporary cohorts of patients has intrinsic limitations. The lack of follow-up data is another limitation of this study. Finally, the reported findings reflect our own experience. The results can be different for other surgeons.
CONCLUSION
In conclusion, in our study, the systematic and unrestricted use of BIMA was associated with a high incidence of perioperative adverse events (particularly sternal complications). Individualization of the revascularization strategy to the patient and combined use of alternative arterial conduits (in particular the radial artery) are probably preferable to systematic use of BIMA.
SUPPLEMENTARY MATERIAL
Supplementary material is available at EJCTS online.
